| Company Name |
Goldline Pharmaceutical Ltd |
| Face Value |
10 |
| BSE Code |
544759 |
| Year End |
202603 |
| Full Year |
| Equity (Rs.Cr.) |
9.60 |
| B.V. Rs. |
21.00 |
| Sales Rs. Cr. |
31.20 |
| NP Rs. Cr. |
4.12 |
| NP Var% |
42.00 |
| Div% |
0.00 |
| CPS Rs. |
4.50 |
| EPS Rs. |
4.30 |
| Traded Value(Rs.Lakhs) |
5.61 |
| 52 Week High |
60.00 |
| 52 Week Low |
37.00 |
| Price BSE |
38.00 |
| Price NSE |
0.00 |
| Market Capital(Rs. Cr.) |
36.84 |
| P/C Ratio |
8.40 |
| P/E Ratio |
8.90 |
| Price Vs.BV |
1.81 |
| Year End |
202603 |
| Sales Rs. Cr. |
9.79 |
| NP Rs. Cr. |
1.89 |
| NP Var % |
0.00 |
| Year End |
0 |
| Sales |
0.00 |
| OPM |
0.00 |
| NP |
0.00 |
| NP Var% |
|
| EPS |
0.00 |
| PE |
0.00 |
|
|